# Enphase Energy, Inc.: financial statements, quarterly

ENPH · Nasdaq · CIK 1463101 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/enph.md) · [Financials](/companies/enph/financials.md) · [Filings](/companies/enph/filings.md) · [Insiders](/companies/enph/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/enph/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [303 d](/filings/0001463101-26-000013.md) | [263](/filings/0001463101-25-000056.md) | [303](/filings/0001463101-25-000101.md) | [381](/filings/0001463101-25-000112.md) | [383 d](/filings/0001463101-26-000013.md) | [356](/filings/0001463101-26-000047.md) | [363](/filings/0001463101-26-000081.md) | [410](/filings/0001463101-26-000102.md) | [343 d](/filings/0001463101-26-000013.md) | [283](/filings/0001463101-26-000047.md) | [292](/filings/0001463101-26-000081.md) | [293](/filings/0001463101-26-000102.md) |
| Cost of revenue | $m | [156 d](/filings/0001463101-26-000013.md) | [148](/filings/0001463101-25-000056.md) | [166](/filings/0001463101-25-000101.md) | [203](/filings/0001463101-25-000112.md) | [184 d](/filings/0001463101-26-000013.md) | [188](/filings/0001463101-26-000047.md) | [193](/filings/0001463101-26-000081.md) | [214](/filings/0001463101-26-000102.md) | [191 d](/filings/0001463101-26-000013.md) | [183](/filings/0001463101-26-000047.md) | [117](/filings/0001463101-26-000081.md) | [166](/filings/0001463101-26-000102.md) |
| Gross profit | $m | [147 d](/filings/0001463101-26-000013.md) | [116](/filings/0001463101-25-000056.md) | [137](/filings/0001463101-25-000101.md) | [178](/filings/0001463101-25-000112.md) | [198 d](/filings/0001463101-26-000013.md) | [168](/filings/0001463101-26-000047.md) | [170](/filings/0001463101-26-000081.md) | [196](/filings/0001463101-26-000102.md) | [152 d](/filings/0001463101-26-000013.md) | [100](/filings/0001463101-26-000047.md) | [175](/filings/0001463101-26-000081.md) | [127](/filings/0001463101-26-000102.md) |
| Research and development | $m | [55.3 d](/filings/0001463101-26-000013.md) | [54.2](/filings/0001463101-25-000056.md) | [48.9](/filings/0001463101-25-000101.md) | [47.8](/filings/0001463101-25-000112.md) | [50.4 d](/filings/0001463101-26-000013.md) | [50.2](/filings/0001463101-26-000047.md) | [45.4](/filings/0001463101-26-000081.md) | [47.3](/filings/0001463101-26-000102.md) | [46.2 d](/filings/0001463101-26-000013.md) | [44.9](/filings/0001463101-26-000047.md) | [45.7](/filings/0001463101-26-000081.md) | [45.2](/filings/0001463101-26-000102.md) |
| Operating income | $m | [(10.2) d](/filings/0001463101-26-000013.md) | [(29.1)](/filings/0001463101-25-000056.md) | [1.8](/filings/0001463101-25-000101.md) | [49.8](/filings/0001463101-25-000112.md) | [54.8 d](/filings/0001463101-26-000013.md) | [31.9](/filings/0001463101-26-000047.md) | [37.0](/filings/0001463101-26-000081.md) | [66.2](/filings/0001463101-26-000102.md) | [22.4 d](/filings/0001463101-26-000013.md) | [(29.6)](/filings/0001463101-26-000047.md) | [51.5](/filings/0001463101-26-000081.md) | [6.5](/filings/0001463101-26-000102.md) |
| Interest expense | $m | [2.3 d](/filings/0001463101-24-000024.md) | [2.2](/filings/0001463101-24-000071.md) | [2.2](/filings/0001463101-25-000101.md) | [2.2](/filings/0001463101-25-000112.md) | [2.3 d](/filings/0001463101-26-000013.md) | [2.0](/filings/0001463101-26-000047.md) | [0.8](/filings/0001463101-26-000081.md) | [0.8](/filings/0001463101-26-000102.md) | [0.8 d](/filings/0001463101-26-000013.md) | [0.6](/filings/0001463101-26-000047.md) | [0.3](/filings/0001463101-26-000081.md) | [0.3](/filings/0001463101-26-000102.md) |
| Income tax | $m | [(8.7) d](/filings/0001463101-26-000013.md) | [4.6](/filings/0001463101-25-000056.md) | [0.4](/filings/0001463101-25-000101.md) | [5.0](/filings/0001463101-25-000112.md) | [7.5 d](/filings/0001463101-26-000013.md) | [17.2](/filings/0001463101-26-000047.md) | [5.2](/filings/0001463101-26-000081.md) | [10.4](/filings/0001463101-26-000102.md) | [(0.0) d](/filings/0001463101-26-000013.md) | [(6.5)](/filings/0001463101-26-000047.md) | [25.8](/filings/0001463101-26-000081.md) | [(27.0)](/filings/0001463101-26-000102.md) |
| Net income | $m | [20.9 d](/filings/0001463101-26-000013.md) | [(16.1)](/filings/0001463101-25-000056.md) | [10.8](/filings/0001463101-25-000101.md) | [45.8](/filings/0001463101-25-000112.md) | [62.2 d](/filings/0001463101-26-000013.md) | [29.7](/filings/0001463101-26-000047.md) | [37.1](/filings/0001463101-26-000081.md) | [66.6](/filings/0001463101-26-000102.md) | [38.7 d](/filings/0001463101-26-000013.md) | [(7.4)](/filings/0001463101-26-000047.md) | [36.1](/filings/0001463101-26-000081.md) | [23.4](/filings/0001463101-26-000102.md) |
| Diluted EPS | $ per share | not reported | [(0.12)](/filings/0001463101-25-000056.md) | [0.08](/filings/0001463101-25-000101.md) | [0.33](/filings/0001463101-25-000112.md) | not reported | [0.22](/filings/0001463101-26-000047.md) | [0.28](/filings/0001463101-26-000081.md) | [0.50](/filings/0001463101-26-000102.md) | not reported | [(0.06)](/filings/0001463101-26-000047.md) | [0.27](/filings/0001463101-26-000081.md) | [0.17](/filings/0001463101-26-000102.md) |
| Basic EPS | $ per share | not reported | [(0.12)](/filings/0001463101-25-000056.md) | [0.08](/filings/0001463101-25-000101.md) | [0.34](/filings/0001463101-25-000112.md) | not reported | [0.23](/filings/0001463101-26-000047.md) | [0.28](/filings/0001463101-26-000081.md) | [0.51](/filings/0001463101-26-000102.md) | not reported | [(0.06)](/filings/0001463101-26-000047.md) | [0.27](/filings/0001463101-26-000081.md) | [0.18](/filings/0001463101-26-000102.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [289](/filings/0001463101-26-000013.md) | [254](/filings/0001463101-24-000071.md) | [252](/filings/0001463101-24-000119.md) | [256](/filings/0001463101-24-000141.md) | [369](/filings/0001463101-26-000013.md) | [350](/filings/0001463101-25-000056.md) | [371](/filings/0001463101-25-000101.md) | [402](/filings/0001463101-25-000112.md) | [474](/filings/0001463101-26-000102.md) | [498](/filings/0001463101-26-000047.md) | [529](/filings/0001463101-26-000081.md) | [380](/filings/0001463101-26-000102.md) |
| Current assets | $m | [2,444](/filings/0001463101-25-000024.md) | [2,303](/filings/0001463101-24-000071.md) | [2,242](/filings/0001463101-24-000119.md) | [2,361](/filings/0001463101-24-000141.md) | [2,327](/filings/0001463101-26-000013.md) | [2,197](/filings/0001463101-25-000056.md) | [2,289](/filings/0001463101-25-000101.md) | [2,392](/filings/0001463101-25-000112.md) | [2,607](/filings/0001463101-26-000102.md) | [1,830](/filings/0001463101-26-000047.md) | [1,951](/filings/0001463101-26-000081.md) | [1,883](/filings/0001463101-26-000102.md) |
| Total assets | $m | [3,383](/filings/0001463101-25-000024.md) | [3,233](/filings/0001463101-24-000071.md) | [3,167](/filings/0001463101-24-000119.md) | [3,264](/filings/0001463101-24-000141.md) | [3,250](/filings/0001463101-26-000013.md) | [3,106](/filings/0001463101-25-000056.md) | [3,179](/filings/0001463101-25-000101.md) | [3,320](/filings/0001463101-25-000112.md) | [3,510](/filings/0001463101-26-000102.md) | [2,724](/filings/0001463101-26-000047.md) | [2,919](/filings/0001463101-26-000081.md) | [2,877](/filings/0001463101-26-000102.md) |
| Current liabilities | $m | [532](/filings/0001463101-25-000024.md) | [554](/filings/0001463101-24-000071.md) | [530](/filings/0001463101-24-000119.md) | [567](/filings/0001463101-24-000141.md) | [660](/filings/0001463101-26-000013.md) | [1,159](/filings/0001463101-25-000056.md) | [1,163](/filings/0001463101-25-000101.md) | [1,171](/filings/0001463101-25-000112.md) | [1,262](/filings/0001463101-26-000102.md) | [482](/filings/0001463101-26-000047.md) | [565](/filings/0001463101-26-000081.md) | [460](/filings/0001463101-26-000102.md) |
| Total liabilities | $m | [2,399](/filings/0001463101-25-000024.md) | [2,310](/filings/0001463101-24-000071.md) | [2,282](/filings/0001463101-24-000119.md) | [2,333](/filings/0001463101-24-000141.md) | [2,417](/filings/0001463101-26-000013.md) | [2,295](/filings/0001463101-25-000056.md) | [2,298](/filings/0001463101-25-000101.md) | [2,325](/filings/0001463101-25-000112.md) | [2,423](/filings/0001463101-26-000102.md) | [1,622](/filings/0001463101-26-000047.md) | [1,737](/filings/0001463101-26-000081.md) | [1,635](/filings/0001463101-26-000102.md) |
| Long-term debt | $m | [1,294](/filings/0001463101-25-000024.md) | [1,199](/filings/0001463101-24-000071.md) | [1,199](/filings/0001463101-24-000119.md) | [1,200](/filings/0001463101-24-000141.md) | [1,201](/filings/0001463101-26-000013.md) | [571](/filings/0001463101-25-000056.md) | [572](/filings/0001463101-25-000101.md) | [572](/filings/0001463101-25-000112.md) | [572](/filings/0001463101-26-000102.md) | [573](/filings/0001463101-26-000047.md) | [573](/filings/0001463101-26-000081.md) | [573](/filings/0001463101-26-000102.md) |
| Current portion of debt | $m | [0.0](/filings/0001463101-25-000024.md) | [97.3](/filings/0001463101-24-000071.md) | [98.6](/filings/0001463101-24-000119.md) | [99.9](/filings/0001463101-24-000141.md) | [101](/filings/0001463101-26-000013.md) | [631](/filings/0001463101-25-000056.md) | [631](/filings/0001463101-25-000101.md) | [632](/filings/0001463101-25-000112.md) | [632](/filings/0001463101-26-000102.md) | [0.0](/filings/0001463101-26-000047.md) | [0.0](/filings/0001463101-26-000081.md) | [0.0](/filings/0001463101-26-000102.md) |
| Shareholders' equity | $m | [984](/filings/0001463101-26-000013.md) | [923](/filings/0001463101-25-000056.md) | [885](/filings/0001463101-25-000101.md) | [931](/filings/0001463101-25-000112.md) | [833](/filings/0001463101-26-000013.md) | [811](/filings/0001463101-26-000047.md) | [881](/filings/0001463101-26-000081.md) | [995](/filings/0001463101-26-000102.md) | [1,087](/filings/0001463101-26-000102.md) | [1,102](/filings/0001463101-26-000047.md) | [1,182](/filings/0001463101-26-000081.md) | [1,242](/filings/0001463101-26-000102.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.5 d](/filings/0001463101-26-000013.md) | [49.2](/filings/0001463101-25-000056.md) | [127 d](/filings/0001463101-25-000101.md) | [170 d](/filings/0001463101-25-000112.md) | [167 d](/filings/0001463101-26-000013.md) | [48.4](/filings/0001463101-26-000047.md) | [26.6 d](/filings/0001463101-26-000081.md) | [13.9 d](/filings/0001463101-26-000102.md) | [47.6 d](/filings/0001463101-26-000013.md) | [103](/filings/0001463101-26-000047.md) | [40.3 d](/filings/0001463101-26-000081.md) | [0.1 d](/filings/0001463101-26-000102.md) |
| Capital expenditure | $m | [20.1 d](/filings/0001463101-26-000013.md) | [7.4](/filings/0001463101-25-000056.md) | [9.6 d](/filings/0001463101-25-000101.md) | [8.5 d](/filings/0001463101-25-000112.md) | [8.1 d](/filings/0001463101-26-000013.md) | [14.6](/filings/0001463101-26-000047.md) | [8.3 d](/filings/0001463101-26-000081.md) | [8.0 d](/filings/0001463101-26-000102.md) | [9.7 d](/filings/0001463101-26-000013.md) | [19.9](/filings/0001463101-26-000047.md) | [14.4 d](/filings/0001463101-26-000081.md) | [11.5 d](/filings/0001463101-26-000102.md) |
| Share repurchases | $m | [100.0 d](/filings/0001463101-26-000013.md) | [42.0](/filings/0001463101-25-000056.md) | [99.9 d](/filings/0001463101-25-000101.md) | [49.8 d](/filings/0001463101-25-000112.md) | [200 d](/filings/0001463101-26-000013.md) | [100.0](/filings/0001463101-26-000047.md) | [30.0 d](/filings/0001463101-26-000081.md) | [0.0 d](/filings/0001463101-26-000102.md) | [0.0 d](/filings/0001463101-26-000013.md) | [0.0](/filings/0001463101-26-000047.md) | [0.0 d](/filings/0001463101-26-000081.md) | [0.0 d](/filings/0001463101-26-000102.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [146](/filings/0001463101-24-000071.md) | [145](/filings/0001463101-24-000119.md) | [144](/filings/0001463101-24-000141.md) | [136](/filings/0001463101-25-000056.md) | [136](/filings/0001463101-25-000101.md) | [140](/filings/0001463101-25-000112.md) | [136](/filings/0001463101-26-000047.md) | [135](/filings/0001463101-26-000081.md) | [133](/filings/0001463101-26-000102.md) | [131](/filings/0001463101-26-000047.md) | [135](/filings/0001463101-26-000081.md) | [135](/filings/0001463101-26-000102.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 132,314,277 at 2026-10-23, from the cover of the [10-Q filed 2026-10-27](/filings/0001463101-26-000102.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:13 ET. No prices; not investment advice.